ACAclaris Therapeutics, Inc. ACRS · NASDAQ
$3.97 -0.63% (-$0.03)
- Market cap
- $587.3M
- Enterprise value
- $568.2M
- P/E
- -
- Forward P/E
- -
- PEG
- -
- P/S
- 71.5x
- P/FCF
- -
- EV/EBITDA
- -
- ROIC
- -61.6%
- Gross margin
- 95.6%
- Net margin
- -921.5%
- Dividend yield
- -
- Payout ratio
- -
- Net debt/EBITDA
- -
- Beta
- 0.80
- Free float
- 75.4%
About the company
Aclaris Therapeutics, Inc. (ACRS) is a biotechnology company focused on researching, developing, and commercializing therapeutics for dermatological conditions and skin-related health issues. The company concentrates on innovative therapeutic approaches and medicinal products that target various dermatological indications, including skin disorders and autoimmune conditions. Aclaris Therapeutics, Inc. has a strong research foundation and collaborates with skin experts and dermatologists to develop effective treatment methods. With its innovations and focus on skin health, investing in Aclaris Therapeutics, Inc. (ACRS) shares may present an interesting investment opportunity for investors interested in the biotechnology and medical sectors.
Sector
Healthcare
Industry
Biotechnology
CEO
Neal S. Walker
Employees
71
Headquarters
Wayne
Valuation
Is today's price reasonable?
Growth and estimates
Is it growing, and what comes next?
- What to watch: Revenue fell by 36% a year over the last 3 years.
- What to watch: Analysts expect revenue to fall by 21% this fiscal year.
Profitability and quality
How much of the revenue is left, and how well does the company use its capital?
- What to watch: The company made a loss over the last 12 months.
Financial health
Can it carry its debt?
- What speaks for it: It has no debt and holds $19.2M in cash.
- What to watch: It passes only 2 of the 9 points of the Piotroski financial health test.
Capital and dividends
What does the company do with the money it earns?
Analysts
What do the professionals think, and is it changing?
Owners and insiders
Who holds the stock, and what is management doing?
Segments
Which part of the company is growing?
Peer comparison
How does it compare with similar companies?
Price and risk
How does the stock behave?
Statements
Every number